Full Text
Cost-Effectiveness of Ibrutinib in Patients with Relapsed or Refractory (RR) Chronic Lymphocytic Leukaemia (CLL) in England

Abstract

Authors

F Hassan S Peng E Dorman S Sorensen G Thompson J Lee

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×